Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
14,476,121
-
Share change
-
+1,855,826
-
Total reported value
-
$104,126,600
-
Put/Call ratio
-
104%
-
Price per share
-
$7.20
-
Number of holders
-
51
-
Value change
-
+$13,345,733
-
Number of buys
-
31
-
Number of sells
-
11
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2014
As of 31 Mar 2014,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,476,121 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, JANE STREET GROUP, LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.